B Group Inc’s Insmed INSM Stock Holding History

B Group Inc’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-158	Closed	-$22.8K	–	19
2025 Q3	$22.8K	Sell	158 -154,842	-100%	-$19M	0.02%	20
2025 Q2	$15.6M	Sell	155,000 -107,500	-41%	-$8.22M	12.01%	2
2025 Q1	$20M	Sell	262,500 -87,500	-25%	-$6.69M	17.16%	2
2024 Q4	$24.2M	Buy	+350,000	New	+$25.2M	14.77%	3

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

B Group Inc's INSM Position: Q4 2025 in Review

B Group Inc sold out of Insmed (INSM) in Q4 2025, closing a stake of 158 shares — an estimated $22.8K sold.

B Group Inc first reported a position in INSM in Q4 2024 and held it in 4 quarters. The position peaked at $24.2M in Q4 2024. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

B Group Inc reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
B Group Inc sold 158 Insmed shares in Q4 2025, an estimated $22.8K.
B Group Inc first reported a position in Insmed in Q4 2024 and held it in 4 quarters.
B Group Inc's Insmed position peaked at $24.2M in Q4 2024.
677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on B Group Inc's 13F filing for Q4 2025, filed 17 Feb 2026.